Target intelligence / Profile preview

RNA G-quadruplex (RG4)

Target
RG4
Molecular classification
Nucleic acid, Non-canonical RNA structure, Regulatory RNA element
01

Overview

RNA G-quadruplexes (RG4s) are non-canonical secondary structures formed within guanine-rich RNA sequences through Hoogsteen base pairing, which organizes four guanine bases into a planar G-tetrad [1]. These structures are highly stable and prevalent throughout the human transcriptome, particularly within the untranslated regions (UTRs) and splicing junctions of messenger RNAs [2]. RG4s function as critical post-transcriptional regulators, influencing processes such as translation efficiency, alternative splicing, and mRNA stability [3]. In oncology, RG4s are frequently located in the transcripts of potent proto-oncogenes like MYC, KRAS, and NRAS, where their stabilization by small molecules can downregulate protein expression and inhibit tumor progression [4]. Beyond cancer, RG4s are implicated in the pathogenesis of neurodegenerative diseases, such as ALS and FTD, where they contribute to the formation of toxic RNA aggregates and sequester essential RNA-binding proteins [5]. Therapeutic targeting of RG4s involves the use of small-molecule ligands designed to stabilize these structures, offering a novel approach to modulating gene expression and inhibiting viral replication in pathogens like HIV-1 and SARS-CoV-2 [6]. However, a major challenge in the clinical development of RG4-targeted therapies is achieving sufficient specificity to avoid cross-reactivity with DNA G-quadruplexes and minimizing global effects on the cellular translatome [4]. Sources: [1] Kwok, C. K., et al. (2016). Nature Methods, 13(10), 841-844. [2] Fay, M. M., et al. (2017). Molecules, 22(4), 497. [3] Cammas, A., & Millevoi, S. (2017). Nucleic Acids Research, 45(4), 1566-1579. [4] Xu, S., et al. (2021). Signal Transduction and Targeted Therapy, 6(1), 1-20. [5] Simone, R., et al. (2015). Scientific Reports, 5, 16532. [6] Ruggiero, E., & Richter, S. N. (2018). Nucleic Acids Research, 46(11), 5369-5383.

Other names
G-quadruplex RNARNA G4G4-RNAG-rich RNA secondary structure
02

Mechanism of action

Small molecule ligands interact with RNA G-quadruplexes primarily through pi-pi stacking with the external G-tetrads and electrostatic interactions with the phosphate backbone or loops [1][3]. Stabilization of the RG4 structure in the 5' UTR of mRNA creates a physical barrier that inhibits the scanning of the 43S pre-initiation complex or the progression of the ribosome, thereby suppressing translation [2]. In other contexts, stabilization can modulate alternative splicing by masking or exposing splice sites, or interfere with the binding of RNA-binding proteins (RBPs) that regulate mRNA decay or transport [4].

03

Biological functions

Translation regulationmRNA stability controlAlternative splicing regulationTelomere maintenanceStress granule formationmRNA localizationPolyadenylation signaling
04

Disease associations

CancerAmyotrophic lateral sclerosis (ALS)Frontotemporal dementia (FTD)Viral infection (e.g., HIV-1, SARS-CoV-2, Zika)Fragile X syndromePrion diseases
05

Safety considerations

Lack of selectivity between RNA and DNA G-quadruplexes leading to off-target genomic instability [4]Potential for widespread transcriptomic disruption due to the prevalence of RG4 motifsInduction of nucleolar stress and ribosomal biogenesis inhibitionCytotoxicity in non-cancerous cells with high metabolic activityInterference with essential RNA-binding protein functions
06

Interacting drugs

Pidnarulex (CX-5461)

6 more in the full profile.

07

Biomarkers

BG4 antibody (G-quadruplex specific antibody)rG4-seq (RNA G-quadruplex sequencing)G4-RP (G-quadruplex-triggered RNA polymerase arrest)Thioflavin T (ThT) fluorescenceNMM (N-methyl mesoporphyrin IX) staining

Beyond the preview

Go deeper on RNA G-quadruplex (RG4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA G-quadruplex (RG4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call